UA36163A - Method for preventing oligoanuric form of acute renal failure - Google Patents

Method for preventing oligoanuric form of acute renal failure

Info

Publication number
UA36163A
UA36163A UA99116127A UA99116127A UA36163A UA 36163 A UA36163 A UA 36163A UA 99116127 A UA99116127 A UA 99116127A UA 99116127 A UA99116127 A UA 99116127A UA 36163 A UA36163 A UA 36163A
Authority
UA
Ukraine
Prior art keywords
oligoanuric
preventing
renal failure
acute renal
rats
Prior art date
Application number
UA99116127A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олександр Степанович Федорук
Александр Степанович Федорук
Василь Павлович Пішак
Василий Павлович Пишак
Анатолій Іванович Гоженко
Анатолий Иванович Гоженко
Віктор Миколайович Магаляс
Виктор Николаевич Магаляс
Original Assignee
Буковинська державна медична академія
Буковинская Государственная Медицинская Академия
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Буковинська державна медична академія, Буковинская Государственная Медицинская Академия filed Critical Буковинська державна медична академія
Priority to UA99116127A priority Critical patent/UA36163A/en
Publication of UA36163A publication Critical patent/UA36163A/en

Links

Abstract

The invention relates to medicine, namely to the pathological physiology. A method for preventing the oligoanuric form of the acute renal failure as a result of the subcutaneous administration of 1% aqueous solution of mercury bichloride to the rats in a dose of 5 mg per kg of body weight consists in using hyperosmolar sodium chloride solution.
UA99116127A 1999-11-10 1999-11-10 Method for preventing oligoanuric form of acute renal failure UA36163A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99116127A UA36163A (en) 1999-11-10 1999-11-10 Method for preventing oligoanuric form of acute renal failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99116127A UA36163A (en) 1999-11-10 1999-11-10 Method for preventing oligoanuric form of acute renal failure

Publications (1)

Publication Number Publication Date
UA36163A true UA36163A (en) 2001-04-16

Family

ID=74182601

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99116127A UA36163A (en) 1999-11-10 1999-11-10 Method for preventing oligoanuric form of acute renal failure

Country Status (1)

Country Link
UA (1) UA36163A (en)

Similar Documents

Publication Publication Date Title
GB9925962D0 (en) Organic compounds
CO4700482A1 (en) FORMULATIONS OF A MONOMER INSULIN ANALOG
YU10699A (en) Application of glp-1, glp-1 analogues and glp-1 derivatives in the production of medicines
HK1014861A1 (en) Use of carbazole compounds in the manufacture of a medicament for the treatment of congestive heart failure
ZA889679B (en) Redox systems for brain-targeted drug delivery
IL124977A0 (en) Oral administration of effective amounts of forms of hyaluronic acid
GR1003658B (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
GB2352972A (en) Use of dexmedetomidine for icu sedation
ES2135342A1 (en) Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene
IL141232A0 (en) Use of camptothecin derivatives, with reduced gastrointestinal toxicity
UA36163A (en) Method for preventing oligoanuric form of acute renal failure
HUP9903410A2 (en) Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
UA36162A (en) Method for modeling polyuric form of acute renal failure
PL323496A1 (en) Pharmaceutic composition obtained by adding a taste improving agent to a drug
CO5021217A1 (en) STABLE COMPOSITIONS OF MITOXANTRONE, PROCEDURE TO PREPARE THEM; USE OF SUCH COMPOSITIONS AND MEDICATIONS THAT INCLUDE SUCH SOLUTIONS FOR THE TREATMENT OF CANCER DISEASES
IL151627A0 (en) Divided dose therapies with vascular damaging activity
HRP20010110B1 (en) Pharmaceutical composition with antitumor activity on the basis of carboplatin
UA36164A (en) Method for modeling experimental acute renal failure
YU5301A (en) Use of campttothecin derivatives, with reduced gastrointestinal toxicity
UA38479A (en) Method for modeling osteoporosis
UA29084A (en) The method for increasing of heart contractility in case of experimental acute heart failure
Lin et al. Toxicity of a single oral dose of N-ethylphenylacetamide in rats
EA199800848A1 (en) HYPOLIPIDEMIC AND ANTI-ATEROSCLEROTIC MEANS
MD1854F1 (en) Method of treatment in the congestive cardiac insufficiency
RU97118477A (en) APPLICATION OF RALOXIFEN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN PREVENTION OF BREAST CANCER